ShangPharma Innovation partners with Icahn School of Medicine

Venture capital firm ShangPharma Innovation Inc. is teaming up with the Icahn School of Medicine at Mount Sinai  (ISMMS) to accelerate the development of early-stage therapeutics. As part of the multi-year strategic collaboration, ShangPharma pledges to provide multiple years of R&D funding at ISMMS ’s clinical institutes in New York. The goal, according to a prepared statement released Tuesday, is to further ISMMS’s objectives of validating drug targets and establishing programs to discover…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news